Therefore, we evaluated the contribution of the acetate–FFAR3/FFAR2 molecular circuit to the regulation of NAFLD/NASH development by feeding Ffar3−/−, Ffar2−/− and wild-type (WT) mice HFC or HFC+IN for 20 weeks. Here, FFAR3 is linked to metabolic dysfunction-associated steatotic liver disease.